SCHEMBL29322126

CCCCCCCCC(CCCCCC)C(=O)OCCCCCC(=O)NCC(CN(C)CCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)OC(=O)CCCCCOC(=O)C(CCCCCC)CCCCCCCC

nearest known ligand 0.36

Predicted protein targets (top 14)

	gene	UniProt	supporting neighbours	confidence
▸	ASAH1	Q13510	1/20	0.36

▸	TLR2	O60603	5/20	0.35

▸	SIRT2	Q8IXJ6	1/20	0.35

▸	HDAC8	Q9BY41	4/20	0.34

▸	HDAC3	O15379	2/20	0.34

▸	HDAC6	Q9UBN7	2/20	0.34

▸	HDAC1	Q13547	1/20	0.34

▸	HDAC2	Q92769	1/20	0.34

▸	NPC1	O15118	1/20	0.33

▸	RAB9A	P51151	1/20	0.33

▸	SMN1; SMN2	Q16637	1/20	0.33

▸	PPARG	P37231	1/20	0.33

▸	BCHE	P06276	1/20	0.33

▸	ACHE	P22303	1/20	0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL13030091	0.76	TLR2 (0.38)	ASAH1TLR2HDAC8HDAC3HDAC6
SCHEMBL18642002	0.73	ALDH1A1 (0.46)	HDAC8HDAC3HDAC6HDAC1HDAC2
SCHEMBL9697547	0.71	ALDH1A1 (0.45)	SMN1; SMN2
SCHEMBL6569812	0.71	PRKCA (0.50)	—
SCHEMBL13030107	0.70	TLR2 (0.38)	ASAH1TLR2HDAC8HDAC3HDAC6
SCHEMBL13029976	0.70	TLR2 (0.45)	TLR2PPARG
SCHEMBL13030064	0.69	TLR2 (0.39)	TLR2PPARG
SCHEMBL13030090	0.69	CERT1 (0.41)	ASAH1HDAC8HDAC3HDAC6HDAC1
SCHEMBL17912420	0.69	CNR2 (0.36)	TLR2SIRT2NPC1RAB9APPARG
SCHEMBL17912422	0.69	CNR2 (0.36)	TLR2SIRT2NPC1RAB9APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4400491-A1	NOVEL LIPIDS USED FOR NUCLEIC ACID DELIVERY AND LIPID NANOPARTICLE COMPOSITION	Themedium Therapeutics Co., Ltd (CN)	2024-07-17	—	—	EP	disclosed